HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

remetinostat

Also Known As:

methyl 4-(8-(hydroxyamino)-8-oxooctanoyl)oxybenzoate

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzoates: 426
        remetinostat: 3
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Benzoates: 426
      - remetinostat: 3

Experts

1.	Aasi, Sumaira Z: 2 articles (01/2022 - 01/2021)
2.	Bailey, Irene: 2 articles (01/2022 - 01/2021)
3.	Eichstadt, Shaundra: 2 articles (01/2022 - 01/2021)
4.	Kilgour, James M: 2 articles (01/2022 - 01/2021)
5.	Sarin, Kavita Y: 2 articles (01/2022 - 01/2021)
6.	Shah, Aatman: 2 articles (01/2022 - 01/2021)
7.	Do, Hanh N: 1 article (01/2021)
8.	Li, Shufeng: 1 article (01/2021)
9.	Mirza, Amar: 1 article (01/2021)
10.	Oro, Anthony E: 1 article (01/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "All participants applied 1% remetinostat gel three times daily for 6 weeks, with measurements of tumor diameter conducted at baseline and week 8. Surgical excision of the remaining tumor was conducted at the end of the study and microscopic evaluation was performed. " 01/01/2023 - "This critical review summarizes the advancement in the chemical composition of bioactives used in skin cancer, such as sinecatechins, BIL-010t, patidegib, gingerol, curcumin, remetinostat, epigallocatechin-3-gallate, etc. Furthermore, this review specifically addresses the progress in transdermal delivery systems for melanoma and nonmelanoma cancer therapy, emphasizing advances in physical and chemical penetration enhancement and nanocarrier-assisted transdermal systems."
2.	Basal Cell Carcinoma (Rodent Ulcer) 01/01/2021 - "Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma."
3.	Skin Neoplasms (Skin Cancer) 01/01/2023 - "This critical review summarizes the advancement in the chemical composition of bioactives used in skin cancer, such as sinecatechins, BIL-010t, patidegib, gingerol, curcumin, remetinostat, epigallocatechin-3-gallate, etc. Furthermore, this review specifically addresses the progress in transdermal delivery systems for melanoma and nonmelanoma cancer therapy, emphasizing advances in physical and chemical penetration enhancement and nanocarrier-assisted transdermal systems."
4.	Melanoma (Melanoma, Malignant) 01/01/2023 - "This critical review summarizes the advancement in the chemical composition of bioactives used in skin cancer, such as sinecatechins, BIL-010t, patidegib, gingerol, curcumin, remetinostat, epigallocatechin-3-gallate, etc. Furthermore, this review specifically addresses the progress in transdermal delivery systems for melanoma and nonmelanoma cancer therapy, emphasizing advances in physical and chemical penetration enhancement and nanocarrier-assisted transdermal systems."
5.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/01/2022 - "Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat."

Related Drugs and Biologics

1.	Histone Deacetylase Inhibitors
2.	Curcumin
3.	epigallocatechin gallate (epigallocatechin-3-gallate)
4.	gingerol

Related Therapies and Procedures

1.	Therapeutics